News Medical on MSN7d
EU-funded Vigilant network aims to develop broad-spectrum antiviral drugs
Pandemics threaten both human health and the global economy. Vaccines are an essential part of the fight against pandemics, but they are only available months after the outbreak ...
NanoViricides Engages CRO for Phase II Clinical Trial
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
As H5N1 Is Detected In San Francisco, A Panel Discusses Next Steps
San Francisco confirmed that a child in the city became the first case of H5N1. A panel of biotech leaders discussed what ...
health.wusf.usf.edu2d
Trump's 'stop-work' order for PEPFAR cuts off anti-HIV drugs for patients
As a result of the new administration's actions, health centers funded by PEPFAR, the U.S. President's Emergency Plan for ...
Investornewsbreaks Nanoviricides (NYSE American: NNVC) Partners With CRO To Advance NV-387 Antiviral Drug To Phase II Trials
NanoViricides, Inc. (NYSE American: NNVC) announced it has engaged a Clinical Research Organization (“CRO”) to conduct a Phase II clinical trial for ...